tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Iovance Biotherapeutics price target raised to $11 from $10 at Barclays
PremiumThe FlyIovance Biotherapeutics price target raised to $11 from $10 at Barclays
25d ago
Iovance upgraded to Outperform from Market Perform at Citizens
Premium
The Fly
Iovance upgraded to Outperform from Market Perform at Citizens
25d ago
Iovance Biotherapeutics price target lowered to $16 from $17 at Chardan
Premium
The Fly
Iovance Biotherapeutics price target lowered to $16 from $17 at Chardan
26d ago
Iovance Biotherapeutics reports Q4 EPS (18c), consensus (18c)
PremiumThe FlyIovance Biotherapeutics reports Q4 EPS (18c), consensus (18c)
26d ago
Iovance Biotherapeutics announces results from trial for TIL cell therapy
Premium
The Fly
Iovance Biotherapeutics announces results from trial for TIL cell therapy
26d ago
IOVA Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
IOVA Earnings this Week: How Will it Perform?
28d ago
Largest borrow rate increases among liquid names
PremiumThe FlyLargest borrow rate increases among liquid names
4M ago
Iovance Biotherapeutics price target raised to $1.50 from $1 at Goldman Sachs
Premium
The Fly
Iovance Biotherapeutics price target raised to $1.50 from $1 at Goldman Sachs
4M ago
Iovance Biotherapeutics Reports Strong Q3 2025 Growth
Premium
Company Announcements
Iovance Biotherapeutics Reports Strong Q3 2025 Growth
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100